BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kulkarni AV, Kumar P, Rao NP, Reddy N. Terlipressin-induced ischaemic skin necrosis. BMJ Case Rep 2020;13:e233089. [PMID: 31948983 DOI: 10.1136/bcr-2019-233089] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Kulkarni AV, Rabiee A, Mohanty A. Management of Portal Hypertension. Journal of Clinical and Experimental Hepatology 2022. [DOI: 10.1016/j.jceh.2022.03.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Kulkarni AV, Arab JP, Premkumar M, Benítez C, Tirumalige Ravikumar S, Kumar P, Sharma M, Reddy DN, Simonetto DA, Rao PN. Terlipressin has stood the test of time: Clinical overview in 2020 and future perspectives. Liver Int 2020;40:2888-905. [DOI: 10.1111/liv.14703] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
3 Zhou Y, Zeng J, Song L, Wang C. Clinical characteristics and treatment of terlipressin-induced ischemic skin necrosis: A synthesis of 35 literature reported cases. J Clin Pharm Ther 2022. [PMID: 35460093 DOI: 10.1111/jcpt.13671] [Reference Citation Analysis]
4 Kulkarni AV, Kumar K, Candia R, Arab JP, Tevethia HV, Premkumar M, Sharma M, Menon B, Rao GV, Reddy ND, Rao NP. Prophylactic Perioperative Terlipressin Therapy for Preventing Acute Kidney Injury in Living Donor Liver Transplant Recipients: A Systematic Review and Meta-Analysis. Journal of Clinical and Experimental Hepatology 2022;12:417-27. [DOI: 10.1016/j.jceh.2021.06.019] [Reference Citation Analysis]
5 Jain G, Chandran P, Patnaik I, Patel NB. Terlipressin-induced skin necrosis. BMJ Case Rep 2021;14:e246678. [PMID: 34844973 DOI: 10.1136/bcr-2021-246678] [Reference Citation Analysis]